FDA 483 - BPI Labs LLC - April 30, 2021
FDA 483 for BPI Labs LLC on April 30, 2021. Product: Drugs. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for BPI Labs LLC on April 30, 2021. Product: Drugs. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
BPI Labs LLCInspection Date
April 30, 2021
Product Type
Drugs
Office
Florida District OfficeID: 3de5a3ed-2aad-48c7-9e0e-ec35aa5f7fbf
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox